+6 more ↓
38%
Finnrick rating
#8 of 54 CJC-1295 vendors
7 of 18 classifiable tests passed
customers 4.3★ (10)
methodology · Purity focus
Finnrick analysis · CJC-1295

Qing Li Peptide's CJC-1295 record is constrained by repeated purity misses despite passing identity and acceptable fill results. Recent 99.7-99.9% results improve the trajectory, but earlier 96.2-97.9% tests keep the profile volatile.

methodology →
vendor intelligence report
Vendor Intelligence Report: Qing Li Peptide

Domain records, Wayback captures and supplier profiles point away from the Hong Kong-facing history Qing Li presents. The report maps cloned storefronts, exposed staff records and a Pioneer Peptide fee pattern seen in buyer reports.

33 pages6 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.05
89%
35
2
Tirzepatide
$0.47
80%
44
3
Retatrutide
$1.00
79%
119
4
Ipamorelin
$0.60
70%
16
5
Melanotan II
$0.40
66%
7
6
PT-141
-
64%
6
7
Cagrilintide
$1.80
57%
4
8
Sermorelin
$1.00
54%
5
9
Survodutide
$3.00
47%
3
10
CJC-1295selected
$1.40
38%
18
11
BPC-157
$0.70
36%
31
12
Tesamorelin
$1.80
34%
21
13
MOTS-c
$0.50
31%
4
14
TB-500
$1.20
22%
18
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%17 Jul 2025: 19%18 Jul 2025: 26%18 Jul 2025: 33%28 Jul 2025: 31%16 Aug 2025: 29%25 Sept 2025: 27%3 Oct 2025: 25%9 Oct 2025: 24%15 Jan 2026: 23%4 Feb 2026: 28%2 Mar 2026: 27%2 Mar 2026: 26%6 Mar 2026: 30%7 Mar 2026: 34%13 May 2026: 38%2 Aug 2026: current 38%19%23%38%Jul 25Aug 26
Showing CJC-1295 tests only
Qing Li Peptide CJC-1295 test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
13 May 2026Pass
Tested
lab nameView COA
7 Mar 2026Pass
Tested
lab nameView COA
6 Mar 2026Pass
Tested
lab nameView COA
2 Mar 2026Fail
Tested
lab nameView COA
2 Mar 2026Fail
Tested
lab nameView COA
4 Feb 2026Pass
Tested
lab nameView COA
15 Jan 2026Fail
Tested
lab nameView COA
9 Oct 2025Fail
Tested
lab nameView COA
3 Oct 2025Fail
Tested
lab nameView COA
25 Sep 2025Fail
Tested
lab nameView COA
1-10 of 18

About Qing Li Peptide test results from Finnrick

Qing Li Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 14 peptides and 331 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Qing Li Peptide peptides in this dataset are Melanotan II (7 tests), CJC-1295 (18 tests) and Semaglutide (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.